Trypanosoma cruzi Reactivation After Chimeric Antigen Receptor T-Cell Therapy

Open Forum Infect Dis. 2024 Jan 23;11(1):ofad698. doi: 10.1093/ofid/ofad698. eCollection 2024 Jan.

Authors

Bayan Alahmdi¹, Avneet Kaur², Samantha E Jacobs³, Timothy Sullivan³, Maya Barghash⁴, Sarah Taimur³

Affiliations

¹ Division of Infectious Diseases, Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
² Division of Infectious Diseases, Department of Medicine, City of Hope, Duarte, California, USA.
³ Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
⁴ Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Abstract

https://tidbitapp.io/tidbits/trypanosoma-cruzi-reactivation-post-chimeric-antigen-receptor-t-cell-therapy/update.

Keywords: Trypanosoma cruzi; chimeric antigen receptor T-cell therapy; diffuse large B-cell lymphoma; hematopoietic cell transplant.

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.